Home › Funds › Logos Global Management LP › DNTH

Logos Global Management LP position in DNTH

DIANTHUS THERAPEUTICS INC · Health Care

Logos Global Management LP reported holding 800,000 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$78.0M, representing 3.36% of its reported portfolio and ranking #10 among its reported holdings. Logos Global Management LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)800.00K sh
Reported value held$77.98M
Portfolio Weight3.36%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's DNTH position evolved

Logos Global Management LP first disclosed a stake in DNTH in Q3 2025 at 200,000 shares (US$7.9M). The position peaked in Q2 2026 at 800,000 shares, worth US$78.0M. Across 4 filings, Logos Global Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 800,000 shares valued at US$78.0M — an increase of 400,000 shares quarter over quarter.. Notable position changes include a 58% increase in Q4 2025 (shares rose 104% over the following quarter), a 27% increase in Q1 2026 (shares rose 16% over the following quarter), a 100% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 200.00K $7.87M New
Q4 2025 315.00K $12.98M Add
Q1 2026 400.00K $33.57M Add
Q2 2026 800.00K $77.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has Logos Global Management LP held DNTH?

Logos Global Management LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Logos Global Management LP's current position in DNTH?

As of Q2 2026, Logos Global Management LP holds 800.00K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $77.98M, representing 3.36% of its reported portfolio and ranking #10.

Has Logos Global Management LP been buying or selling DNTH?

In the latest 13F filing (Q2 2026), Logos Global Management LP increased its position in DNTH. The position peaked in Q2 2026 at 800.00K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.